$YCBD ($YCBD) is expected to release its quarterly earnings data on Tuesday, December 16th after market close, per Finnhub. Analysts are expecting revenue of $4,796,040 and earnings of -$0.07 per share.
You can see Quiver Quantitative's $YCBD stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
$YCBD Hedge Fund Activity
We have seen 7 institutional investors add shares of $YCBD stock to their portfolio, and 18 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CITADEL ADVISORS LLC removed 59,142 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $71,561
- VANGUARD GROUP INC added 51,563 shares (+inf%) to their portfolio in Q3 2025, for an estimated $62,391
- GSA CAPITAL PARTNERS LLP removed 37,465 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $45,332
- VIRTU FINANCIAL LLC removed 19,762 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $23,912
- SCIENTECH RESEARCH LLC added 15,406 shares (+inf%) to their portfolio in Q3 2025, for an estimated $18,641
- JANE STREET GROUP, LLC removed 13,644 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $16,509
- SASSICAIA CAPITAL ADVISERS LLC added 12,000 shares (+inf%) to their portfolio in Q3 2025, for an estimated $14,520
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$YCBD Analyst Ratings
Wall Street analysts have issued reports on $YCBD in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Maxim Group issued a "Buy" rating on 08/20/2025
To track analyst ratings and price targets for $YCBD, check out Quiver Quantitative's $YCBD forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
